Seelos Therapeutics (SEEL)

Seelos Therapeutics (SEEL) Financial Statements


Seelos Therapeutics Financial Overview

Seelos Therapeutics's market cap is currently ―. The company's EPS TTM is $-13.385; its P/E ratio is -0.06; Seelos Therapeutics is scheduled to report earnings on April 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 419.00K$ 875.00K$ 40.00K$ 0.00$ 0.00
Gross Profit$ 419.00K$ 875.00K$ 40.00K--
EBIT$ -29.49M$ -9.19M$ -15.64M$ -19.60M$ -21.27M
EBITDA$ -29.48M$ -9.18M$ -15.59M$ -19.60M$ -21.27M
Net Income Common Stockholders$ -29.50M$ -13.43M$ -18.66M$ -19.60M$ -21.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.80M$ 14.10M$ 15.50M$ 30.51M$ 41.25M
Total Assets$ 11.85M$ 23.68M$ 22.75M$ 40.51M$ 52.67M
Total Debt$ 15.34M$ 16.78M$ 20.12M$ 21.40M$ 19.27M
Net Debt$ 9.54M$ 2.68M$ 4.62M$ -9.11M$ -21.98M
Total Liabilities$ 59.07M$ 44.30M$ 33.36M$ 32.63M$ 26.44M
Stockholders Equity$ -47.21M$ -20.68M$ -10.61M$ 7.88M$ 26.23M
Cash Flow-
Free Cash Flow$ -5.90M$ -10.35M$ -13.09M$ -11.07M$ -20.39M
Operating Cash Flow$ -5.90M$ -10.35M$ -13.09M$ -11.07M$ -20.39M
Investing Cash Flow-----
Financing Cash Flow$ -2.31M$ 8.87M$ -1.89M$ 334.00K$ -126.00K
Currency in USD

Seelos Therapeutics Earnings and Revenue History

Seelos Therapeutics Debt to Assets

Seelos Therapeutics Cash Flow

Seelos Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis